1. Home
  2. HRMY vs MNR Comparison

HRMY vs MNR Comparison

Compare HRMY & MNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • MNR
  • Stock Information
  • Founded
  • HRMY 2017
  • MNR 2017
  • Country
  • HRMY United States
  • MNR United States
  • Employees
  • HRMY N/A
  • MNR N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • MNR
  • Sector
  • HRMY Health Care
  • MNR
  • Exchange
  • HRMY Nasdaq
  • MNR Nasdaq
  • Market Cap
  • HRMY 2.1B
  • MNR 1.7B
  • IPO Year
  • HRMY 2020
  • MNR 2023
  • Fundamental
  • Price
  • HRMY $33.22
  • MNR $16.03
  • Analyst Decision
  • HRMY Buy
  • MNR Strong Buy
  • Analyst Count
  • HRMY 9
  • MNR 2
  • Target Price
  • HRMY $47.00
  • MNR $25.50
  • AVG Volume (30 Days)
  • HRMY 1.3M
  • MNR 166.8K
  • Earning Date
  • HRMY 10-29-2024
  • MNR 11-12-2024
  • Dividend Yield
  • HRMY N/A
  • MNR 22.51%
  • EPS Growth
  • HRMY N/A
  • MNR N/A
  • EPS
  • HRMY 2.11
  • MNR N/A
  • Revenue
  • HRMY $681,879,000.00
  • MNR $873,766,000.00
  • Revenue This Year
  • HRMY $24.63
  • MNR $52.27
  • Revenue Next Year
  • HRMY $18.04
  • MNR $3.80
  • P/E Ratio
  • HRMY $15.77
  • MNR N/A
  • Revenue Growth
  • HRMY 25.83
  • MNR 21.20
  • 52 Week Low
  • HRMY $26.03
  • MNR $14.40
  • 52 Week High
  • HRMY $41.61
  • MNR $21.19
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 44.15
  • MNR 48.08
  • Support Level
  • HRMY $32.37
  • MNR $15.20
  • Resistance Level
  • HRMY $36.68
  • MNR $16.66
  • Average True Range (ATR)
  • HRMY 2.02
  • MNR 0.52
  • MACD
  • HRMY -0.07
  • MNR 0.07
  • Stochastic Oscillator
  • HRMY 20.73
  • MNR 54.75

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

About MNR Mach Natural Resources LP

Mach Natural Resources LP is an independent upstream oil and gas company focused on the acquisition, development and production of oil, natural gas and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas and the panhandle of Texas.

Share on Social Networks: